Verified Nov 2026
Other
·
Ann Arbor, Michigan
·
Since 1999
Terumo Cardiovascular, founded in 1999 and headquartered in Ann Arbor, Michigan, makes medical devices for cardiac and vascular surgery, including heart-lung machines, oxygenators, surgical stabilizers, and autotransfusion systems. It is a subsidiary of Terumo Corporation and has an estimated 1,000-5,000 employees and an estimated $250-500M revenue band. The company serves the medical industry, with facilities in the U.S., Japan, the U.K., and Costa Rica. In 2025 it signed a new $30 million agreement with Orchestra BioMed.
Terumo Cardiovascular at a glance
Revenue
$250-500M
Est. band
Employees
1,000-5,000
Founded
1999
Headquarters
Ann Arbor, Michigan
Import activity
1009
Industries
Automotive
Electric Vehicles
Construction
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
1009
Named foreign suppliers
14
Top origins
Japan · South Korea · China · Singapore
Shared foreign counterparties do not establish that these companies buy from Terumo Cardiovascular.
What this tells a buyer
No customs data is available, and the most recent reported development is the October 2025 announcement of MDR certification for its CDI OneView monitoring system.
The company's listed products include heart-lung machines, oxygenators, surgical stabilizers, and autotransfusion systems used in cardiopulmonary bypass and vascular procedures.
The company is privately held as a Terumo Corporation subsidiary and reports no named customers in the record.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
Terumo Cardiovascular, founded in 1999 and headquartered in Ann Arbor, Michigan, makes medical devices for cardiac and vascular surgery, including heart-lung machines, oxygenators, surgical stabilizers, and autotransfusion systems. It is a subsidiary of Terumo Corporation and has an estimated 1,000-5,000 employees and an estimated $250-500M revenue band. The company serves the medical industry, with facilities in the U.S., Japan, the U.K., and Costa Rica. In 2025 it signed a new $30 million agreement with Orchestra BioMed.
At a glance
Attribute | Detail |
|---|---|
Founded | 1999 |
Headquarters | Ann Arbor, Michigan |
Employees | 1,000-5,000 |
Revenue | $250-500M (estimated) |
What Terumo Cardiovascular makes
The company's listed products include heart-lung machines, oxygenators, surgical stabilizers, and autotransfusion systems used in cardiopulmonary bypass and vascular procedures.
Products and capabilities described on the company's own site include LED (source: terumocv.com).
Trade and customs footprint
No customs data is available, and the most recent reported development is the October 2025 announcement of MDR certification for its CDI OneView monitoring system. US customs bill-of-lading records list 1009 inbound shipments across 14 foreign suppliers, with top origins including Japan · South Korea · China · Singapore.
Latest developments
2026-08-28 — J065 - Terumo Cardiovascular System | CLEATUS (cleat.ai)
2026-03-19 — Tata Elxsi launches Offshore Development Center for Terumo’s medical device engineering (techcircle.in)
2025-10-28 — Orchestra, Terumo terminate drug-eluting balloon distro deal (massdevice.com)
2025-10-28 — Orchestra BioMed and Terumo Enter into New $30 Million (globenewswire.com)
2025-10-21 — Terumo Announces MDR Certification for CDI OneView Monitoring System (terumo-europe.com)
2025-08-25 — Terumo to buy organ preservation device maker OrganOx for $1.5B (massdevice.com)
Company details
The company is privately held as a Terumo Corporation subsidiary and reports no named customers in the record. Terumo Cardiovascular was founded in 1999, has an estimated 1,000-5,000 employees, and is headquartered in Ann Arbor, Michigan.
Frequently asked questions
What does Terumo Cardiovascular do?
Terumo Cardiovascular, founded in 1999 and headquartered in Ann Arbor, Michigan, makes medical devices for cardiac and vascular surgery, including heart-lung machines, oxygenators, surgical stabilizers, and autotransfusion systems. It is a subsidiary of Terumo Corporation and has an estimated 1,000-5,000 employees and an estimated $250-500M revenue band. The company serves the medical industry, with facilities in the U.S., Japan, the U.K., and Costa Rica. In 2025 it signed a new $30 million agreement with Orchestra BioMed.
Where is Terumo Cardiovascular headquartered?
Terumo Cardiovascular is headquartered in Ann Arbor, Michigan (6200 Jackson Road, Ann Arbor, Michigan, 48103).
When was Terumo Cardiovascular founded?
Terumo Cardiovascular was founded in 1999.
How big is Terumo Cardiovascular?
Terumo Cardiovascular has an estimated 1,000-5,000 employees, with revenue in the $250-500M range (estimated).
Does Terumo Cardiovascular import from overseas suppliers?
US customs bill-of-lading records show 1009 inbound shipments for Terumo Cardiovascular, with top origins including Japan · South Korea · China · Singapore.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.